Direkt zum Inhalt
Merck
  • Effects of tobacco smoking during pregnancy on oxidative stress in the umbilical cord and mononuclear blood cells of neonates.

Effects of tobacco smoking during pregnancy on oxidative stress in the umbilical cord and mononuclear blood cells of neonates.

Journal of biomedical science (2014-12-31)
Ednildes de Almeida Olympio Rua, Marcella Leite Porto, Jean Pierre Louzada Ramos, Breno Valentim Nogueira, Silvana S Meyrelles, Elisardo Corral Vasquez, Thiago C Pereira
ZUSAMMENFASSUNG

Although cigarette smoke is known to be a complex mixture of over 4000 substances that can lead to damage through active or passive smoking, its mechanisms and biochemical consequences in pregnancy and neonates are not yet fully understood. Therefore, in the present study, we propose to study the impact of smoking during gestation on the viability of blood mononuclear cells (MNC) from umbilical cords of newborns to assess the degree of oxidative stress and cell viability. After childbirth, the cord blood and the umbilical cord were immediately collected in public hospitals in Greater Vitoria, ES, Brazil. Flow cytometry was used to analyze the cord blood followed by biochemical and histological tests to analyze possible changes in the umbilical cord. Pregnant smokers had a reduction of MNC viability from the umbilical cord (10%), an increase in the production of reactive oxygen species (ROS) and an increase in cell apoptosis (~2-fold) compared to pregnant non-smokers. In the umbilical cord, it was observed an increase of advanced oxidation protein products - AOPP (~2.5-fold) and a loss of the typical architecture and disposition of endothelial cells from the umbilical artery. These data suggest that maternal cigarette smoking during pregnancy (even in small amounts) may compromise the viability of MNC cells and damage the umbilical cord structure, possibly by excessive ROS bioavailability.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Kaliumiodid, ACS reagent, ≥99.0%
Sigma-Aldrich
Kaliumiodid, ReagentPlus®, 99%
Sigma-Aldrich
Propidiumjodid, ≥94.0% (HPLC)
Sigma-Aldrich
Kaliumiodid, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Kaliumiodid, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, 99%
Sigma-Aldrich
Kaliumiodid, ≥99.99% trace metals basis
Sigma-Aldrich
Kaliumiodid, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
Kaliumiodid, suitable for plant cell culture
Sigma-Aldrich
Propidiumjodid -Lösung
Supelco
Kaliumiodid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Kaliumiodid, AnhydroBeads, −10 mesh, 99.998% trace metals basis
Sigma-Aldrich
Propidiumjodid, ≥94% (HPLC)
Sigma-Aldrich
Kaliumiodid, BioXtra, ≥99.0%
Sigma-Aldrich
Kaliumiodid, tested according to Ph. Eur.
Sigma-Aldrich
Kaliumiodid, puriss., meets analytical specification of Ph. Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)